Denali Therapeutics Inc (DNLI)
R&D Expenses
$400.72M
TTM · Period ending: · USD
DNLI R&D Expenses
Latest reported$400.72Mperiod ending
Latest reported$400.72Mperiod ending
DNLI TTM R&D Expenses ($75.70M → $400.72M)
TTM R&D Expenses
High-resolution chart · PNG
DNLI r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 400,720,000 | |
| 406,397,000 | |
| 418,778,000 | |
| 420,660,000 | |
| 416,948,000 | |
| 405,651,000 | |
| 396,440,000 | |
| 404,456,000 | |
| 395,955,000 | |
| 402,076,000 | |
| 423,876,000 | |
| 408,184,000 | |
| 406,233,000 | |
| 401,450,000 | |
| 358,732,000 | |
| 334,497,000 | |
| 318,270,000 | |
| 291,244,000 | |
| 265,353,000 | |
| 252,220,000 | |
| 234,365,000 | |
| 221,806,000 | |
| 212,615,000 | |
| 209,423,000 | |
| 208,263,000 | |
| 206,995,000 | |
| 193,382,000 | |
| 181,740,000 | |
| 159,517,000 | |
| 159,767,000 | |
| 143,183,000 | |
| 121,745,000 | |
| 109,939,000 | |
| 76,809,000 | |
| 74,460,000 | |
| 72,719,000 | |
| 82,023,000 | |
| 78,595,500 | |
| 75,702,000 |